Lowest effective 131I activity for lymph node metastases therapy of differentiated thyroid cancer patients; Dosimetry-based model for estimation

被引：0
|
作者：
Stebner, V. [1 ]
Phaosricharoen, J. [1 ]
Herrmann, K. [1 ]
Jentzen, W. [1 ]
机构：
[1] Univ Duisburg Essen, Fac Med, Dept Nucl Med, Essen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
E-PW049
引用
收藏
页码：S396 / S396
页数：1
相关论文
共 50 条
  • [21] Efficacy and Survival Analysis of 131I Therapy for Bone Metastases from Differentiated Thyroid Cancer
    Qiu, Zhong-Ling
    Song, Hong-Jun
    Xu, Yan-Hong
    Luo, Quan-Yong
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (10): : 3078 - 3086
  • [22] Bone Metastases of Differentiated Thyroid Cancer: The Importance of Early Diagnosis and 131I Therapy on Prognosis
    Zanotti-Fregonara, Paolo
    Rubello, Domenico
    Hindie, Elif
    JOURNAL OF NUCLEAR MEDICINE, 2008, 49 (11) : 1902 - 1903
  • [23] 131I therapy of thyroid cancer patients
    Reiners, C
    Farahati, J
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE, 1999, 43 (04): : 324 - 335
  • [24] Interrupted 131I Procedures for Patients With Differentiated Thyroid Cancer
    Karls, Shawn
    Abikhzer, Gad
    Tamilia, Michael
    Probst, Stephan
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (04) : 247 - 249
  • [25] Dosimetry in the therapy of metastatic differentiated thyroid cancer administering high 131I activity: the experience of Busto Arsizio Hospital (Italy)
    Bianchi, L.
    Baroli, A.
    Lomuscio, G.
    Pedrazzini, L.
    Pepe, A.
    Pozzi, L.
    Chiesa, C.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 56 (06): : 515 - 521
  • [26] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Jin, Pingyan
    Feng, Huijuan
    Ouyang, Wei
    Wu, Juqing
    Chen, Pan
    Wang, Jing
    Sun, Yungang
    Xian, Jialang
    Huang, Liuhua
    RADIATION AND ENVIRONMENTAL BIOPHYSICS, 2018, 57 (02) : 169 - 177
  • [27] Radiation dose rates of differentiated thyroid cancer patients after 131I therapy
    Pingyan Jin
    Huijuan Feng
    Wei Ouyang
    Juqing Wu
    Pan Chen
    Jing Wang
    Yungang Sun
    Jialang Xian
    Liuhua Huang
    Radiation and Environmental Biophysics, 2018, 57 : 169 - 177
  • [28] Effect of 131I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
    Rui, Zhongying
    Wu, Ruixin
    Zheng, Wei
    Wang, Xuan
    Meng, Zhaowei
    Tan, Jian
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [29] Clinical pathway of metabolic therapy with 131I in differentiated thyroid cancer
    Saiz, I. Blanco
    Apinaniz, E. Anda
    Arribas, J. Pineda
    Moreno, F. Caudepon
    Iglesias, A. Fernandez
    Jimenez, M. Huarte
    Munoz, A. I. de Miguel
    Aristorena, M. I. Irigoyen
    Girones, E. Goni
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (03): : 178 - 187
  • [30] Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer
    Gortan, Fatma Arzu
    Yuksel, Alptug Ozer
    Gulaldi, Nedim Cuneyt Murat
    Coskun, Nazim
    Akca, Ceren Deniz Kapulu
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 260 - 268
12345